CTEPH News

June 5, 2020June 5, 2020

Bayer Offering Grants Up to $1M to Advance PAH, CTEPH Research and Care

Bayer has opened its second annual Pulmonary Hypertension Accelerated Bayer (PHAB) Awards, a grant funding program to support clinical research projects into pulmonary hypertension (PH), particularly those focused on pulmonary ... Read more

April 6, 2020April 6, 2020

Balloon Pulmonary Angioplasty May Safely Treat Inoperable CTEPH

CTEPH News, News

Balloon pulmonary angioplasty (BPA) is a safe and effective, minimally invasive treatment for people with inoperable chronic thromboembolic pulmonary hypertension (CTEPH), according to a study from the U.K. The ... Read more

March 18, 2020March 19, 2020

Major Bleed Risk Higher With Warfarin Than Xarelto in CTEPH Patients, Study Finds

CTEPH News, News

Among people with chronic thromboembolic pulmonary hypertension (CTEPH), certain anticoagulants may reduce the risk of serious bleeding more than others, a new study shows. The study, “Real-life data of ... Read more

January 3, 2020January 3, 2020

Actelion Pulls Requests for Opsumit to Treat Inoperable CTEPH to Gather More Data

CTEPH News, News

Actelion Pharmaceuticals has withdrawn all ongoing worldwide requests for expanded approval of Opsumit (macitentan), a pulmonary arterial hypertension (PAH) medicine, to treat adults with inoperable chronic thromboembolic pulmonary hypertension ... Read more

August 9, 2019August 9, 2019

Heart Transplant Program at UC San Diego Recognized for 1-year Survival Rate of 98.7%, Best in US

CTEPH News, News

The heart transplant program at the University of California San Diego Health has achieved the best one-year patient survival rate in the U.S., with surgeons working at the Cardiovascular ... Read more

August 2, 2019August 2, 2019

Analyzing Exhaled Breath in Differing Positions May Be ‘Simple and Safe’ Way of Monitoring CTEPH

CTEPH News, News, PH News

Analysis of gas exhaled in differing positions, like sitting or laying flat, could be a noninvasive and simple alternative to right heart catheterization in evaluating and managing people with chronic ... Read more

August 1, 2019August 2, 2019

Adempas May Improve Endothelial Cells’ Function in CTEPH, Study Suggests

CTEPH News, News

The vasodilator Adempas (riociguat) increases the ability of endothelial progenitor cells to halt vascular remodeling and enhance formation of new blood vessels in chronic thromboembolic pulmonary hypertension (CTEPH), according to a new ... Read more

July 26, 2019July 26, 2019

Specific Heart Rhythm Parameters Help Predict PH, Study Suggests

CTEPH News, News, PAH News, PH News

The heart rhythm of patients with pulmonary hypertension (PH) has limited ability to adjust to changes, compared to unaffected people used as controls in a new pilot study. The ... Read more

June 20, 2019June 27, 2019

Balloon Pulmonary Angioplasty and Adempas Both Effective for Inoperable CTEPH, Analysis Shows

CTEPH News, News

A new meta-analysis assessing balloon pulmonary angioplasty (BPA) and Adempas (riociguat) for treating inoperable chronic thromboembolic pulmonary hypertension (CTEPH) found both treatment strategies to be well-tolerated, and able to ... Read more

CTEPH News

Bayer Offering Grants Up to $1M to Advance PAH, CTEPH Research and Care

Balloon Pulmonary Angioplasty May Safely Treat Inoperable CTEPH

Major Bleed Risk Higher With Warfarin Than Xarelto in CTEPH Patients, Study Finds

Top 10 Pulmonary Hypertension Stories of 2019

Actelion Pulls Requests for Opsumit to Treat Inoperable CTEPH to Gather More Data

Heart Transplant Program at UC San Diego Recognized for 1-year Survival Rate of 98.7%, Best in US

Analyzing Exhaled Breath in Differing Positions May Be ‘Simple and Safe’ Way of Monitoring CTEPH

Adempas May Improve Endothelial Cells’ Function in CTEPH, Study Suggests

Specific Heart Rhythm Parameters Help Predict PH, Study Suggests

Balloon Pulmonary Angioplasty and Adempas Both Effective for Inoperable CTEPH, Analysis Shows

Pin It on Pinterest